These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 33684447)

  • 1. Macrophages bind LDL using heparan sulfate and the perlecan protein core.
    Ng CY; Whitelock JM; Williams H; Kim HN; Medbury HJ; Lord MS
    J Biol Chem; 2021; 296():100520. PubMed ID: 33684447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
    Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
    Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.
    Kaplan M; Aviram M
    Atherosclerosis; 2000 Mar; 149(1):5-17. PubMed ID: 10704609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins.
    Chang MY; Olin KL; Tsoi C; Wight TN; Chait A
    J Biol Chem; 1998 Jun; 273(26):15985-92. PubMed ID: 9632647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis.
    Xu YX; Ashline D; Liu L; Tassa C; Shaw SY; Ravid K; Layne MD; Reinhold V; Robbins PW
    J Lipid Res; 2015 Feb; 56(2):266-76. PubMed ID: 25528754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
    Kaplan M; Aviram M
    Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
    Melrose J; Whitelock J; Xu Q; Ghosh P
    J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.
    Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM
    Matrix Biol; 2014 Apr; 35():112-22. PubMed ID: 24509440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxynitrite modifies the structure and function of the extracellular matrix proteoglycan perlecan by reaction with both the protein core and the heparan sulfate chains.
    Kennett EC; Rees MD; Malle E; Hammer A; Whitelock JM; Davies MJ
    Free Radic Biol Med; 2010 Jul; 49(2):282-93. PubMed ID: 20416372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of synthesis of a large heparan sulfate proteoglycan, perlecan, by thrombin in cultured human coronary smooth muscle cells.
    Yamamoto C; Wakata T; Fujiwara Y; Kaji T
    Biochim Biophys Acta; 2005 Feb; 1722(1):92-102. PubMed ID: 15716125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
    Pillarisetti S
    Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochim Biophys Acta; 1983 Jul; 758(1):70-83. PubMed ID: 6222769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of macrophage glycosaminoglycans in the cellular catabolism of oxidized LDL by macrophages.
    Kaplan M; Williams KJ; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):542-53. PubMed ID: 9555859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
    Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
    J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
    Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
    J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture.
    Fujiwara Y; Kaji T
    Toxicology; 1999 Apr; 133(2-3):159-69. PubMed ID: 10378482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.